Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950146-96-000501
Filing Date
1996-04-01
Accepted
1996-04-01 00:00:00
Documents
6
Period of Report
1995-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 ACCESS PHARMACEUTICALS, INC. 10-K 180598
2 AMENDMENT TO CERTIFICATE OF INCORPORATION EX-3.(I) 2658
3 PATENT PURCHASE AGREEMENT EX-10.16 39382
4 AMENDMENT TO PATENT PURCHASE AGREEMENT EX-10.17 3951
5 CONSENT OF KPMG PEAT MARWICK EX-23 900
6 ACCESS PHARMACEUTICALS FDS EX-27 2385
  Complete submission text file 0000950146-96-000501.txt   232091
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-09314 | Film No.: 96543436
SIC: 2834 Pharmaceutical Preparations